Introduction {#Sec1}
============

Uterine contractions, fetal descent, and cervical dilation are used to assess progression of labor. These related phenomena vary greatly among parturients and may have an incidence on the condition of the fetus. Simulators allow for practice of normal and critical situations at will and at no risk to real patients. Several models for educational simulation of labor and delivery were published in the literature \[[@CR1]--[@CR3]\] and incorporated into a commercially available training simulator \[[@CR4]\]. The cited models make amplitude, frequency, duration, and resting tone of the uterine pressure waveform evolve spontaneously and under the influence of oxytocin and tocolytics. However, the relationships between these variables and cervical dilation are scripted.

A positive feedback loop involving oxytocin plays a central role in the progression of first-stage labor. The hypothalamus releases oxytocin into the bloodstream, which is transported to the uterus and stimulates uterine contractions. The contractions result in descent of the fetus. The descending fetal head causes cervical dilation. Cervical stretch receptors send a signal to the hypothalamus via afferent nerves, stimulating additional release of oxytocin, thereby closing the loop. This loop results in progressively intensifying contractions and dilation over time \[[@CR5]\].

A database for a number of contraction and dilation profiles could be established and used for scripted training simulation purposes. However, realistic simulation of the interaction between oxytocin concentrations, uterine contractions, fetal descent, and dilation, for a number of patient profiles, and possibly under external influences such as administration of exogenous oxytocin and tocolytics, requires a model-based approach. Such a model would not only increase insight in the interacting processes, but also greatly expand the range of scenarios that can be simulated beyond the relatively simple phenomena that can be characterized in a database.

In this innovation paper, we lay the foundation for such a model by proposing an empirical model that simulates oxytocin concentrations and contraction and dilation profiles. The model should be able to run in real, or accelerated, time and should be easy to manipulate to reflect different patients.

Methods {#Sec2}
=======

Basic assumptions are made, similar to the ones in the article of Bastos et al. \[[@CR3]\] and based on understanding of physiological relations, in order to keep the model as simple as possible, while approaching the target data of Zhang et al. \[[@CR6]\]. The subsystems and variables connecting them, as described in the introduction, are reflected in the block diagram of Fig. [1](#Fig1){ref-type="fig"}.Fig. 1Conceptual model for educational simulation of cervical dilation during first-stage labor. Oxt.: oxytocin

The model equations referring to Fig. [1](#Fig1){ref-type="fig"} from left to right are introduced below. The rate of oxytocin release by the hypothalamus *r(t)* in mU/min has a fixed component, reflected in the parameter *P*~*1*~ and depends linearly via a gain *P*~*2*~ on the sensed dilation *d(t)* in centimeters:$$\documentclass[12pt]{minimal}
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Units of parameters can easily be derived from the units of the variables. The change in mass of oxytocin depends on the elimination rate constant *P*~*3*~, the current mass *m(t)* in mU, and the release rate, represented by a first-order pharmacokinetic model:$$\documentclass[12pt]{minimal}
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Dividing the mass by the volume of distribution *P*~*4*~ results in the concentration of oxytocin in mU/mL:$$\documentclass[12pt]{minimal}
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The concentration dependency of contraction frequency *f(t)* in 1/min and contraction amplitude *a(t)* in mm Hg is represented by a sigmoidal curve, Eqs. ([4](#Equ4){ref-type=""}) and ([5](#Equ5){ref-type=""}). For example in Eq. ([4](#Equ4){ref-type=""}), for a concentration equal to zero, the frequency is zero; for a concentration equal to *P*~*6*~, it is 50% of the maximum frequency *P*~*5*~; and for higher concentrations, it tends toward *P*~*5*~. The slope of both pharmacodynamic relationships is governed by *P*~*7*~:$$\documentclass[12pt]{minimal}
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The amplitude has a non-zero baseline *P*~*8*~ and a concentration-dependent part reflected in *P*~*9*~ (the difference between the maximum and baseline amplitude values):$$\documentclass[12pt]{minimal}
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The change in dilation depends on the pressure exerted by the fetus on the cervix *P*~*10*~, which is assumed fixed in this version of the model, and on the product of frequency and amplitude. This second influence is assumed linearly proportional with gain *P*~*11*~. Thus, the resulting uterine model is$$\documentclass[12pt]{minimal}
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Referenced and empirically adjusted parameters are listed in Table [1](#Tab1){ref-type="table"}.Table 1Model parameters. For consistency, all values are given in three significant digitsSymbolDescriptionValueUnitReferenceP~1~Baseline oxytocin release rate in hypothalamus0.740mU/min\[[@CR7]\]P~2~Gain from cervical dilation to oxytocin release rate in hypothalamus50.0mU/(min cm)P~3~Pharmacokinetic parameter: Elimination rate constant0.06931/min\[[@CR3]\]P~4~Pharmacokinetic parameter: Volume of distribution18,700mL\[[@CR8], [@CR9]\]P~5~Maximal concentration frequency0.5001/min\[[@CR2]\]P~6~Pharmacodynamic parameter: Oxytocin concentration resulting in 50% effect7.90mU/mL\[[@CR3]\]P~7~Pharmacodynamic parameter: Slope of sigmoidal curve1.11dimensionless\[[@CR2]\]P~8~Baseline contraction amplitude40.0mm Hg\[[@CR10]\]P~9~Maximal contraction amplitude40.0mm Hg\[[@CR2]\]P~10~Dilation increase due to pressure exerted by the fetus on the cervix1.00 × 10^−3^cm/min\[[@CR11]\]P~11~Dilation increase due to contraction frequency and amplitude1.90 × 10^−2^cm/mm Hg

Equations (1--6) were implemented in MATLAB (MATLAB R2017a, The MathWorks Inc.) using the Euler forward method with an integration step size of 1 min to integrate the two differential equations. Model simulation results are presented and compared to target data obtained from Zhang et al. \[[@CR6]\] for cervical dilation.

Results {#Sec3}
=======

Figure [2](#Fig2){ref-type="fig"} shows simulation results from the initial conditions *d(0)* = 2.00 cm, and *m(0)* = 275 mU, using the parameters listed in Table [1](#Tab1){ref-type="table"}. The stars in Fig. [1](#Fig1){ref-type="fig"} correspond to dilation data for patient A in Zhang et al. \[[@CR6]\]. This patient was admitted at 2 cm and labor progressed to 10 cm with labor considered non-protracted.Fig. 2Simulation results and dilation target data

Discussion {#Sec4}
==========

Simulated dilation matches dilation in a normal patient in an approximation that is considered realistic enough for educational simulation. Parameters *P*~*2*~ and *P*~*11*~ were adjusted to achieve this match. Further research could address which parameters are patient- or population-specific and can be used to simulate different labor types. The model parameter estimation procedure could then be formalized so that a clinical instructor can easily use it to meet his or her educational objectives. Ongoing work involves expanding the set of target data and matching simulation results to them, to enhance model validity and demonstrate the possibility to match different patient profiles. Critical analysis of the pharmacokinetic model may be necessary. It would also be interesting to explore validity of the model for exogenous oxytocin administration.

Conclusion {#Sec5}
==========

An original empirical model for educational simulation of oxytocin concentrations, uterine contractions, and cervical dilation in first-stage labor is presented. Simulation results for cervical dilation match target data for a normal patient. The proposed model forms a sound, explicit basis for taking into account more independent variables and patient profiles, and thereby considerably expand the range of training scenarios that can be simulated.
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